Augmented therapeutic efficacy of an oncolytic herpes simplex virus type 1 mutant expressing ICP34.5 under the transcriptional control of musashi1 promoter in the treatment of malignant glioma

Ryuichi Kanai, Hideyuki Tomita, Yuichi Hirose, Shigeo Ohba, Steven Goldman, Hideyuki Okano, Takeshi Kawase, Takahito Yazaki

Research output: Contribution to journalArticlepeer-review

18 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Augmented therapeutic efficacy of an oncolytic herpes simplex virus type 1 mutant expressing ICP34.5 under the transcriptional control of musashi1 promoter in the treatment of malignant glioma'. Together they form a unique fingerprint.

Medicine & Life Sciences